2024-2025 Request for Proposals

The Melanoma Research Alliance (MRA) is pleased to announce a Request for Proposals (RFP) for pre-clinical, translational, and early clinical research with the potential to produce unusually high impact, near-term advancements in melanoma prevention, detection, diagnosis, and treatment.

This cycle, proposals will be accepted for Established Investigator Awards, Academic-Industry Partnership Award (for Established Investigator Awards), Young Investigator Awards, Pilot Awards, Dermatology Career Development Awards and Special Opportunity Team Science Awards, Academic-Industry Partnership Award (for Special Opportunity Team Science Awards).

MRA plans to support at least $9.2 million in new funding in the 2024-2025 cycle.

Special Opportunities Included in RFP:

• Acral Melanoma Established Investigator, Young Investigator, & Pilot Awards focused on Advancing Translational Research for Acral Melanoma 
• Uveal Melanoma Established Investigator and Young Investigator Awards focused on Advancing Translational Research for Uveal Melanoma
• Uveal Melanoma Pilot Award co-funded with A Cure in Sight (ACIS)
• Team Science and Established Investigator Awards in Pediatric Melanoma co-funded with St. Baldrick's Foundation
• Team Science Award for Translational Research Opportunities from Patients Receiving Neoadjuvant Treatment Approaches
• Radiation Oncology Young Investigator Award co-funded with the American Society for Radiation Oncology (ASTRO)
• Young Investigator Award (YIA) proposals from applicants based in Australia, Israel, or the United Kingdom (UK)

Please Note the Following Key Deadlines:

• September 27, 2024: Letters of Intent (LOI) for Special Opportunity Team Science Awards and Special Opportunity Team Science Academic-Industry Partnership Award due
• October 21, 2024: Eligibility Checklist for Young Investigator & Dermatology Career Development Award applicants due
• November 4, 2024: Proposals for Established Investigator, Young Investigator, Pilot and Dermatology Career Development awards due
• January 6, 2025: Invited Special Opportunity Team Science Award full proposals due
• April 2025: Awardees notified of funding decisions
• June 1, 2025: Project Start Date 

All proposals are due by 11:59 pm Eastern Time. Proposals should be submitted via the proposalCENTRAL online application tool: https://proposalcentral.com/

‍MRA accepts proposals from researchers worldwide and encourages applications from a diverse pool of investigators with respect to race, gender, sexual orientation, ethnicity, national origin, country of residence, and disability. MRA recognizes that diversity in the biomedical research workforce is critical for ensuring that the most creative minds have the opportunity to contribute to realizing our research goals and to ensuring more equitable health outcomes for all.

Questions?

Please contact Joan Levy, PhD - Chief Science Officer - with any questions at jlevy@curemelanoma.org.